Am J Transplant, Volume 21, Suppl 3 Archives - Page 85 of 139 - ATC Abstracts

2021 American Transplant Congress
Kidney Transplant Survival After Borderline Rejection in the Setting of Denovo Dsa Formation
A. P. Bregman¹, S. Jackson², S. Riad¹
¹Department of Nephrology, University of Minnesota, Minneapolis, MN, ²Biostatistics, M-Health Fairview Analytics, Minneapolis, MN
*Purpose: The significance of borderline cellular rejection has been questioned in the past. Data on borderline rejection with deNovo DSA (dnDSA) formation is limited. We…
2021 American Transplant Congress
Kidney Transplantation in Patients with Severe Pulmonary Hypertension: Not an Absolute Contraindication?
B. Prajapati¹, D. Gumber², I. Moinuddin¹, C. Bhati¹, G. Gupta¹, D. Grinnan³, D. Kumar¹
¹Nephrology, Virginia Commonwealth University, Richmond, VA, ²Cardiology, Virginia Commonwealth University, Richmond, VA, ³Pulmonology, Virginia Commonwealth University, Richmond, VA
*Purpose: Severe pulmonary arterial hypertension (PAH) as defined by a pulmonary artery systolic pressure (PASP) >50mmHg is associated with high peri-operative mortality and thus is…
2021 American Transplant Congress
A Comparative Analysis of Kidney Allograft Outcomes in Steroid Use versus Steroid Discontinuation After Basiliximab Induction: Unos Data Base Study
F. Cardarelli, H. Patel, A. Aala
Nephrology, BIDMC, Boston, MA
*Purpose: Basiliximab is a monoclonal antibody produced by recombinant DNA technology used by many transplant centers in the U.S. as induction immunosuppression. When Basiliximab is…
2021 American Transplant Congress
Early Conversion to Belatacept-based Therapy Improves Graft Function in Renal Transplant Patients
N. Huang¹, C. J. Yang², I. Movileanu¹, R. H. Dvorai³, K. M. Ecal¹, R. F. Saidi¹, A. N. Ayla Senay¹, B. Gallay⁴, M. J. Hanlon¹, S. Narsipur⁴, M. R. Laftavi¹, R. Shahbazov¹
¹Surgery, SUNY Upstate Medical University, Syracuse, NY, ²Pharmacy, SUNY Upstate Medical University, Syracuse, NY, ³Pathology, SUNY Upstate Medical University, Syracuse, NY, ⁴Medicine, SUNY Upstate Medical University, Syracuse, NY
*Purpose: Our goal in this study was to assess the impact of early vs late conversion to Belatacept based (Bela) IS in kidney transplant (KT)…
2021 American Transplant Congress
Creatinine Reduction Ratio at 2 Postoperative Day as a Predicting Factor of Long-Term Outcomes After Living Donor Kidney Transplantation
Y. Kinoshita, T. Shinzato, T. Shimizu, D. Iwami
Division of Renal Surgery and Transplantation, Department of Urology, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
*Purpose: Creatinine reduction ratio from 1 to 2 postoperative days (CRR2) under 30% has been defined as a slow graft function (SGF) and used to…
2021 American Transplant Congress
Developing a Robot-assisted Donor Nephrectomy Program in a High Volume Laparoscopic Living Donor Nephrectomy Program
S. S. Lee, N. Vachharajani, M. Pfeiffer, S. Matson, M. Scherer, M. Doyle, J. Wellen, Y. Lin, T. Rice, J. Yu, A. Khan
Abdominal Transplant Surgery, Washington University at St. Louis, St Louis, MO
*Purpose: Three dimensional visualization, improved dexterity and fine instrument control make robotic surgery an attractive option for further improving the safety profile of laparoscopic living…
2021 American Transplant Congress
Single Incision Simultaneous Liver Kidney Transplantation: Outcomes and Feasibility
D. Imai, Y. Sambommatsu, A. Khan, S. Lee, A. Sharma, V. Kumaran, D. Bruno, A. Cotterell, C. Bhati, M. F. Levy
Virginia Commonwealth University, Richmond, VA
*Purpose: Simultaneous liver and kidney transplantation (SLK) is indicated in patients with concomitant end stage liver disease and severe chronic kidney disease or end stage…
2021 American Transplant Congress
Early Experience with Broad Renal Genetic Testing in an Academic Transplant Center
E. Tantisattamo¹, K. Brossart², N. Ioannou², S. McCormick², P. R. Billings², H. Tabriziani²
¹Division of Nephrology, Hypertension and Kidney Transplantation, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, ²Natera, Inc., San Carlos, CA
*Purpose: Genetic testing is an emerging tool in kidney transplantation (KT), particularly to assess risk of recurrent disease in patients with KT and for selection…
2021 American Transplant Congress
Treatment of Bk Virus With Intravenous Immunoglobulin in Pediatric Kidney Transplant
D. Mohammad, D. Kim, R. Baracco, G. Kapur, A. Jain
Pediatric Nephrology and Transplant Services, Children's Hospital of Michigan, Detroit, MI
*Purpose: To study the prevalence of BK viremia (BKV) and BK Virus Nephropathy (BKVN) utilizing plasma BK quantitative Polymerase Chain Reaction (qPCR) and report outcomes…
2021 American Transplant Congress
Donor Derived Cell-free DNA Kinetics Early After Kidney Transplant in Patients with Delayed Graft Function Who Received Kidneys from Donation After Cardiac Death Donors
R. Gumber, M. Abuzeineh, C. Mejia, D. Brennan, F. Naqvi
Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Delayed graft function (DGF) may reduce long-term kidney allograft survival due to ischemia-reperfusion injury and rejection. Donor Derived Cell-Free DNA (dd-cfDNA) is proposed to…